![Aleksandra Rizo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 546 500 $ in data 30/06/2026
Aleksandra Rizo is currently President, Chief Executive Officer & Director at Vividion Therapeutics, Inc. since 2023 and Independent Director at Syndax Pharmaceuticals, Inc. starting in 2024.
Former positions include Chief Medical Officer & Executive Vice President at Geron Corp.
from 2019 to 2022, Executive Director-Strategy & Clinical Leader at Celgene Corp.
from 2018 to 2019, and Senior Director & Team Leader Compound Development at Janssen Research & Development LLC from 2014 to 2018.
Education includes doctorates from the University of Groningen, the University of Tokyo, and Saints Cyril & Methodius University of Skopje.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/03/2026 | 25.000 ( 0,03% ) | 546 500 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/05/2024 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Amministratore Delegato | 24/01/2023 |
| Società | Posizione | Fine |
|---|---|---|
| GERON CORPORATION | Direttore Tecnico/Scientifico/R&S | 08/07/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2019 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 01/03/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Saints Cyril & Methodius University of Skopje
 Saints Cyril & Methodius University of Skopje Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
